PL2146987T3 - Pochodne oksazolidynonu jako antybiotyki - Google Patents
Pochodne oksazolidynonu jako antybiotykiInfo
- Publication number
- PL2146987T3 PL2146987T3 PL08737784T PL08737784T PL2146987T3 PL 2146987 T3 PL2146987 T3 PL 2146987T3 PL 08737784 T PL08737784 T PL 08737784T PL 08737784 T PL08737784 T PL 08737784T PL 2146987 T3 PL2146987 T3 PL 2146987T3
- Authority
- PL
- Poland
- Prior art keywords
- antibiotic derivatives
- oxazolidinone antibiotic
- oxazolidinone
- derivatives
- antibiotic
- Prior art date
Links
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
- 230000003115 biocidal effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IB2007051292 | 2007-04-11 | ||
| IB2008050746 | 2008-02-29 | ||
| PCT/IB2008/051356 WO2008126024A2 (en) | 2007-04-11 | 2008-04-10 | Oxazolidinone antibiotic derivatives |
| EP08737784.2A EP2146987B1 (en) | 2007-04-11 | 2008-04-10 | Oxazolidinone antibiotic derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2146987T3 true PL2146987T3 (pl) | 2016-05-31 |
Family
ID=39722506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08737784T PL2146987T3 (pl) | 2007-04-11 | 2008-04-10 | Pochodne oksazolidynonu jako antybiotyki |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8114867B2 (pl) |
| EP (1) | EP2146987B1 (pl) |
| JP (1) | JP5363457B2 (pl) |
| KR (1) | KR101563752B1 (pl) |
| CN (1) | CN101657450B (pl) |
| AR (1) | AR066012A1 (pl) |
| AU (1) | AU2008238894B2 (pl) |
| BR (1) | BRPI0809667A2 (pl) |
| CA (1) | CA2679069C (pl) |
| CL (1) | CL2008001003A1 (pl) |
| ES (1) | ES2560870T3 (pl) |
| MX (1) | MX2009010641A (pl) |
| PL (1) | PL2146987T3 (pl) |
| RU (1) | RU2506263C2 (pl) |
| TW (1) | TWI415614B (pl) |
| WO (1) | WO2008126024A2 (pl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2492169C2 (ru) | 2007-12-18 | 2013-09-10 | Актелион Фармасьютиклз Лтд | Производные 5-аминоциклилметилоксазолидин-2-она |
| ES2411930T3 (es) | 2008-02-20 | 2013-07-09 | Actelion Pharmaceuticals Ltd. | Compuestos antibióticos azatricíclicos |
| JP5404652B2 (ja) | 2008-02-22 | 2014-02-05 | アクテリオン ファーマシューティカルズ リミテッド | オキサゾリジノン誘導体 |
| EP2321307B1 (en) * | 2008-08-04 | 2012-12-19 | Actelion Pharmaceuticals Ltd. | Tricyclic alkylaminomethyloxazolidinone derivatives |
| KR101294962B1 (ko) | 2008-10-07 | 2013-08-12 | 액테리온 파마슈티칼 리미티드 | 트리사이클 옥사졸리디논 항생제 화합물 |
| CA2738775A1 (en) * | 2008-10-10 | 2010-04-15 | Actelion Pharmaceuticals Ltd | 2-benzothiophenyl-and 2-naphthyl-0xaz0lidin0nes and their azaisostere analogues as antibacterial agents |
| CN102232078B (zh) | 2008-12-12 | 2014-07-16 | 埃科特莱茵药品有限公司 | 5-氨基-2-(1-羟基-乙基)-四氢吡喃衍生物 |
| EP2509997B1 (en) * | 2009-12-07 | 2017-08-30 | i2 Pharmaceuticals, Inc. | Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties |
| EP2377850A1 (en) * | 2010-03-30 | 2011-10-19 | Pharmeste S.r.l. | TRPV1 vanilloid receptor antagonists with a bicyclic portion |
| US8952010B2 (en) | 2011-02-07 | 2015-02-10 | Daiichi Sankyo Company, Limited | Amino group-containing pyrrolidinone derivative |
| CA2842885A1 (en) | 2011-08-11 | 2013-02-14 | Actelion Pharmaceuticals Ltd | Quinazoline-2,4-dione derivatives |
| JP6030146B2 (ja) * | 2011-11-08 | 2016-11-24 | アクテリオン ファーマシューティカルズ リミテッドＡｃｔｅｌｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ | ２−オキソ−オキサゾリジン−３，５−ジイル抗生物質誘導体 |
| EP2785721A1 (en) | 2011-11-30 | 2014-10-08 | Actelion Pharmaceuticals Ltd. | 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| WO2014024056A1 (en) | 2012-08-06 | 2014-02-13 | Daiichi Sankyo Company, Limited | Pyrrolidine derivatives with antibacterial properties |
| WO2014026928A1 (en) * | 2012-08-17 | 2014-02-20 | Basf Se | Process for manufacturing benzoxazinones |
| EA029361B1 (ru) | 2013-04-16 | 2018-03-30 | Идорсиа Фармасьютиклз Лтд | Антибактериальные биароматические производные |
| AR102256A1 (es) * | 2014-10-15 | 2017-02-15 | Actelion Pharmaceuticals Ltd | Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi |
| EP3414246A1 (en) * | 2016-02-08 | 2018-12-19 | Redx Pharma PLC | Antibacterial compounds |
| US10487093B2 (en) | 2016-02-08 | 2019-11-26 | Redx Pharma Plc | Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds |
| GB201602235D0 (en) * | 2016-02-08 | 2016-03-23 | Redx Pharma Plc | Antibacterial compounds |
| GB2550437B (en) | 2016-05-20 | 2021-06-23 | Bugworks Res Inc | Heterocyclic compounds useful as anti-bacterial agents and method for production |
| TW201833120A (zh) | 2017-02-17 | 2018-09-16 | 瑞士商愛杜西亞製藥有限公司 | 芳基噁唑啶酮抗生素化合物 |
| EP3634968B1 (en) * | 2017-06-08 | 2023-01-25 | Bugworks Research, Inc. | Heterocyclic compounds useful as anti-bacterial agents and method for production thereof |
| WO2019106693A1 (en) * | 2017-11-29 | 2019-06-06 | Bugworks Research India Pvt Ltd | Anti-bacterial heterocyclic compounds and their synthesis |
| PT3774790T (pt) * | 2018-03-28 | 2023-04-24 | Bugworks Res Inc | Compostos antibióticos de oxazolidinona e processo de preparação |
| CN117532894B (zh) * | 2023-12-05 | 2024-06-14 | 东莞美泰电子有限公司 | 一种用于保护零件的pu皮革热压贴皮工艺 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996033195A1 (en) | 1995-04-21 | 1996-10-24 | Shinnippon Pharmaceutical Inc. | FUSED IMIDAZO[1,2-a]PYRIDINES |
| CA2228647A1 (en) * | 1995-09-01 | 1997-03-13 | Pharmacia & Upjohn Company | Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings |
| CA2331735A1 (en) | 1998-05-08 | 1999-11-18 | Smithkline Beecham P.L.C. | Phenylurea and phenylthio urea derivatives |
| DE60011570T2 (de) | 1999-01-07 | 2004-11-25 | Wyeth | Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen |
| GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
| EP1400519B1 (en) | 1999-06-28 | 2007-03-07 | Janssen Pharmaceutica N.V. | Respiratory syncytial virus replication inhibitors |
| NZ523749A (en) | 2000-07-26 | 2005-03-24 | Smithkline Beecham P | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| GB0031086D0 (en) | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| WO2003093247A2 (en) * | 2002-04-30 | 2003-11-13 | Orchid Chemicals & Pharmaceuticals Ltd | Antibacterial agents |
| TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
| TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| EP1551829B1 (de) * | 2002-10-10 | 2010-04-07 | Morphochem Aktiengesellschaft Für Kombinatorische Chemie | Neue verbindungen mit antibakterieller aktivität |
| ATE411312T1 (de) * | 2002-12-04 | 2008-10-15 | Glaxo Group Ltd | Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel |
| AR042486A1 (es) | 2002-12-18 | 2005-06-22 | Glaxo Group Ltd | Compuesto de quinolina y naftiridina halosustituido en la posicion 3, procedimiento para preparar el compuesto, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion . |
| DE10316081A1 (de) * | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| EP1484304A1 (en) | 2003-05-28 | 2004-12-08 | Dainippon Ink And Chemicals, Inc. | Process for the preparation of fluorophenylalkylene acid derivatives |
| JP2008502689A (ja) | 2004-06-15 | 2008-01-31 | グラクソ グループ リミテッド | 抗菌剤 |
| FR2872164B1 (fr) * | 2004-06-29 | 2006-11-17 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
| EP1771456A2 (fr) | 2004-07-30 | 2007-04-11 | Palumed SA | Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien |
| DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| JP4887297B2 (ja) | 2004-09-24 | 2012-02-29 | アクテリオン ファーマシューティカルズ リミテッド | 新規二環式抗生物質 |
| WO2006046552A1 (ja) | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
| GB0426373D0 (en) | 2004-12-01 | 2005-01-05 | Syngenta Ltd | Fungicides |
| ES2351613T3 (es) | 2005-03-03 | 2011-02-08 | Santen Pharmaceutical Co., Ltd. | Nuevo compuesto cíclico que tiene un grupo quinolilalquiltio. |
| US7842810B2 (en) | 2005-03-31 | 2010-11-30 | Janssen Pharmaceutica, Nv | Bicyclic pyrazole compounds as antibacterial agents |
| WO2007016610A2 (en) | 2005-08-02 | 2007-02-08 | Glaxo Group Limited | Antibacterial agents |
| WO2007069555A1 (ja) | 2005-12-12 | 2007-06-21 | Meiji Seika Kaisha, Ltd. | 新規16員環4”-o-カルバモイルアザライド誘導体及びその製造方法 |
| CN101374831B (zh) | 2006-01-26 | 2011-04-27 | 埃科特莱茵药品有限公司 | 四氢吡喃抗生素 |
-
2008
- 2008-04-09 CL CL200801003A patent/CL2008001003A1/es unknown
- 2008-04-10 JP JP2010502625A patent/JP5363457B2/ja not_active Expired - Fee Related
- 2008-04-10 US US12/595,711 patent/US8114867B2/en not_active Expired - Fee Related
- 2008-04-10 CN CN200880011810.XA patent/CN101657450B/zh not_active Expired - Fee Related
- 2008-04-10 ES ES08737784.2T patent/ES2560870T3/es active Active
- 2008-04-10 TW TW097113095A patent/TWI415614B/zh not_active IP Right Cessation
- 2008-04-10 EP EP08737784.2A patent/EP2146987B1/en not_active Not-in-force
- 2008-04-10 AU AU2008238894A patent/AU2008238894B2/en not_active Ceased
- 2008-04-10 RU RU2009141310/04A patent/RU2506263C2/ru not_active IP Right Cessation
- 2008-04-10 PL PL08737784T patent/PL2146987T3/pl unknown
- 2008-04-10 AR ARP080101485A patent/AR066012A1/es unknown
- 2008-04-10 WO PCT/IB2008/051356 patent/WO2008126024A2/en not_active Ceased
- 2008-04-10 KR KR1020097023303A patent/KR101563752B1/ko not_active Expired - Fee Related
- 2008-04-10 BR BRPI0809667-8A2A patent/BRPI0809667A2/pt not_active IP Right Cessation
- 2008-04-10 MX MX2009010641A patent/MX2009010641A/es active IP Right Grant
- 2008-04-10 CA CA2679069A patent/CA2679069C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008238894A1 (en) | 2008-10-23 |
| CA2679069C (en) | 2016-06-07 |
| ES2560870T3 (es) | 2016-02-23 |
| JP2010523645A (ja) | 2010-07-15 |
| TW200843780A (en) | 2008-11-16 |
| EP2146987B1 (en) | 2015-12-02 |
| US20100137290A1 (en) | 2010-06-03 |
| EP2146987A2 (en) | 2010-01-27 |
| MX2009010641A (es) | 2009-10-23 |
| AR066012A1 (es) | 2009-07-15 |
| WO2008126024A2 (en) | 2008-10-23 |
| CL2008001003A1 (es) | 2008-10-17 |
| CN101657450A (zh) | 2010-02-24 |
| CA2679069A1 (en) | 2008-10-23 |
| JP5363457B2 (ja) | 2013-12-11 |
| WO2008126024A3 (en) | 2008-12-04 |
| US8114867B2 (en) | 2012-02-14 |
| BRPI0809667A2 (pt) | 2014-10-07 |
| CN101657450B (zh) | 2014-04-23 |
| AU2008238894B2 (en) | 2013-06-20 |
| TWI415614B (zh) | 2013-11-21 |
| KR20090130112A (ko) | 2009-12-17 |
| RU2506263C2 (ru) | 2014-02-10 |
| KR101563752B1 (ko) | 2015-10-27 |
| RU2009141310A (ru) | 2011-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2915813T3 (pl) | Antybiotyki oksazolidynonowe | |
| PL2254887T3 (pl) | Pochodne oksazolidynonu | |
| IL205759A0 (en) | Isoxazolo-pyridine derivatives | |
| IL205753A0 (en) | Isoxazolo-pyridazine derivatives | |
| IL200329A0 (en) | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives | |
| ZA201104423B (en) | Oxadiazole derivatives | |
| IL202020A0 (en) | Spiroindolinone derivatives | |
| ZA201001058B (en) | Quinazolinamide derivatives | |
| ZA201000431B (en) | Indazolamide derivatives | |
| IL205755A0 (en) | Isoxazolo-pyrazine derivatives | |
| ZA201103332B (en) | Tricyclic oxazolidinone antibiotic compounds | |
| IL200618A0 (en) | Aza-pyridopyrimidinone derivatives | |
| IL192401A0 (en) | Indol-3-yl-carbonyl-spiro-piperidine derivatives | |
| IL198645A0 (en) | 5-hydroxymethyl-oxazolidin-2-one derivatives | |
| IL202667A0 (en) | Isoxazole-imidazole derivatives | |
| IL196883A0 (en) | Antibiotic composition | |
| PL2245028T3 (pl) | Pochodne 5-aminocyklilometyloksazolidyn-2-onu | |
| EP2133347A4 (en) | 1-BIARYLAZETIDINONDERIVATE | |
| IL202463A0 (en) | Sulfonyl-quinoline derivatives | |
| IL202159A0 (en) | Piperidine-amide derivatives | |
| PT2173756E (pt) | Derivados de macrolactonas | |
| ZA201002218B (en) | Thiadiazinone derivatives | |
| GB0617222D0 (en) | Antibiotics | |
| GB0702266D0 (en) | 7-Azaindoe derivatives | |
| AP2009005065A0 (en) | Sulfonyl-quinoline derivatives |